Viewing Study NCT03399136



Ignite Creation Date: 2024-05-06 @ 10:57 AM
Last Modification Date: 2024-10-26 @ 12:38 PM
Study NCT ID: NCT03399136
Status: COMPLETED
Last Update Posted: 2022-12-06
First Post: 2018-01-04

Brief Title: Fitness and Longevity in Exercise
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Study Overview

Official Title: Fitness and Longevity in Exercise
Status: COMPLETED
Status Verified Date: 2022-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FLEX
Brief Summary: The study objective was to determine the safety and efficacy of aerobic exercise in older HIV-infected men in a randomized trial comparing different levels of exercise intensity
Detailed Description: The study was a randomized trial of moderate-intensity versus high-intensity aerobic exercise AEX training in older HIV-infected adults Funding was provided by K23 AG024896 PI Oursler and the UMB Claude D Pepper Older Americans Independence Center P60 AG12583 PI Goldberg

The central hypothesis was that high-intensity AEX training is well-tolerated and significantly increases aerobic capacity in older HIV-infected adults

The study met its objectives

1 Scientific AIMS met

1 High-intensity AEX training significantly increases aerobic capacity
2 Both moderate-intensity and high-intensity AEX training improve ambulatory function and endurance
3 Activity of skeletal muscle oxidative enzymes is reduced and associated with aerobic capacity
2 Feasibility Objectives met

1 AEX training is safe and well-tolerated in older HIV-infected adults
2 Skeletal muscle punch biopsy is safe and well-tolerated in older HIV-infected adults
3 Preliminary data was collected on plasma biomarkers of inflammation

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None